{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:56Z","timestamp":1786119176520,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/fjc.0b013e3181a71a78","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T07:16:47Z","timestamp":1244791007000},"page":"435-437","source":"Crossref","is-referenced-by-count":12,"title":["Loop Diuretics in Patients With Heart Failure: Time to Change to Torsemide?"],"prefix":"10.1097","volume":"53","author":[{"given":"Bertram","family":"Pitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nicklas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210208","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","article-title":"Furosemide and the progression of left ventricular dysfunction in experimental heart failure.","volume":"44","author":"McCurley","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R2-1-20210208","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(03)00765-4","article-title":"Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).","volume":"42","author":"Domanski","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R3-1-20210208","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cardfail.2006.03.006","article-title":"Diuretic use, progressive heart failure, and death in patients in the DIG study.","volume":"12","author":"Domanski","year":"2006","journal-title":"J Card Fail"},{"key":"R4-1-20210208","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R5-1-20210208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90812-5","article-title":"Anti-aldosteronergic effect of torasemide.","volume":"205","author":"Uchida","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"R6-1-20210208","doi-asserted-by":"crossref","first-page":"L45","DOI":"10.1016\/S0024-3205(98)00265-3","article-title":"Torsemide inhibits aldosterone secretion in vitro.","volume":"63","author":"Goodfriend","year":"1998","journal-title":"Life Sci"},{"key":"R7-1-20210208","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.","volume":"43","author":"Lopez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R8-1-20210208","first-page":"468","article-title":"Izawa Hideo, Nishizawa T, et al.","volume":"53","author":"Harada","year":"2009","journal-title":"Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide"},{"key":"R9-1-20210208","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cardiores.2005.05.023","article-title":"Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.","volume":"68","author":"Yoshida","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R10-1-20210208","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.108.125278","article-title":"Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.","volume":"53","author":"Lopez","year":"2009","journal-title":"Hypertension"},{"key":"R11-1-20210208","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/hrt.2005.079764","article-title":"Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"key":"R12-1-20210208","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"},{"key":"R13-1-20210208","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction.","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"R14-1-20210208","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehn383","article-title":"Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction.","volume":"29","author":"Palmer","year":"2008","journal-title":"Eur Heart J"},{"key":"R15-1-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R16-1-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-1-20210208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/eurheartj\/ehn543","article-title":"Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.","volume":"30","author":"Ezckowitz","year":"2009","journal-title":"Eur Heart J"},{"key":"R18-1-20210208","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.106.638569","article-title":"Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.","volume":"115","author":"Martos","year":"2007","journal-title":"Circulation"},{"key":"R19-1-20210208","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study.","volume":"4","author":"Cosin","year":"2002","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FJC.0b013e3181a71a78","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:11Z","timestamp":1786038911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200906000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181a71a78","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}